简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
YUE DA INTL
YUE DA INTL (00629.HK): Appoints Dr. Wang Li as Independent Non-Executive Director and Remuneration Committee Chairman; Re-Compliant with Listing Rules
Tags:
YUE DA INTL
00629.HK
Board Changes
2026-08-14
YUE DA INTL(00629.HK): Signs New RMB43 Million Factoring Agreement, Combined Related Transactions in 12 Months Constitute a Major Transaction
Tags:
YUE DA INTL
00629.HK
major transaction
2026-01-09
Featured News
Finance
Diagens (02526.HK): Admitted as Constituent to Hang Seng Composite Index and 22 Other Hang Seng Indices
Finance
AIM Vaccine (06660.HK): Marketing Application Submitted for High-Potency Human Diploid Rabies Vaccine with Optimized Manufacturing Process
Finance
HBM Holdings (02142.HK): Included as a Constituent Stock of Hang Seng Composite Index
Finance
Mech-Mind Robotics (09615.HK): Launches Global Offering, Offer Price Set at HK$101.70 Per Share
Finance
SHEIN Group-W (00625.HK): Launches Global Offering, Offer Price Set at HK$49.50 Per Share
Finance
Impact Therapeutics(07630.HK): Included as a Constituent Stock of Hang Seng Composite Index
Finance
DUIBA GROUP (01753.HK): AI Short Drama Business Posts Notable Revenue Growth, H1 Loss Narrows by About 5% Year-on-Year
Research
HK shares Newly Listed Stocks Tracking Weekly Report: B&K CORP-B Leads with 68% Weekly Gain; INNOGEN-B Down Over 45% Cumulatively in Two Weeks Since Lock-up Expiry - 20260821
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Scan QR Code
Download App